Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 11, 2005, Pages 1153-1155

  Pålsson, Birger ^a   Verbaan, Hans ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cirrhosis; Hepatitis C; Hypersplenism; Interferon; Partial splenic embolization; Ribavirin; Spleen

Indexed keywords

ALPHA INTERFERON; ANALGESIC AGENT; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; MICROSPHERE; NONSTEROID ANTIINFLAMMATORY AGENT; PEGINTERFERON; RECOMBINANT INTERLEUKIN 11; RIBAVIRIN;

ABDOMINAL PAIN; ARTIFICIAL EMBOLISM; ATELECTASIS; BLOOD TOXICITY; CATHETER; CYTOPENIA; DRUG MEGADOSE; DRUG USE; FEVER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERSPLENISM; INJECTION; LIVER CIRRHOSIS; NEUTROPENIA; PARENCHYMA; PARTIAL SPLENIC EMBOLIZATION; PLEURISY; PRIORITY JOURNAL; REVIEW; SPLEEN; SPLEEN ARTERY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; HEPATITIS C, CHRONIC; HUMANS; HYPERSPLENISM;

EID: 27344438027     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200511000-00001     Document Type: Review

References (19)

1. Buti M, San Miguel R, Brosa M, Cabases JM, Medina M, Casado MA, et al. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and cost related to chronic hepatitis C. Hepatology 2005; 42:639-645.
2. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transplant 2003; 9:331-338.
3. Fried MW, Shiftman ML, Reddy R, Smith C, Marinos G, Goncales FL Jr, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-982.
4. Manns MP, McHutchinson JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358:958-965.
5. Peck-Radosavljevic M. Hypersplenism. Eur J Hepatogastroenterol Hepatol 2001; 13:317-323.
6. Afdhal NH, Dieterich DT, Pockros PJ, Schiff ER, Shiffman ML, Sulkowski MS, et al. Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized control study. Gastroenterology 2004; 126:1302-1311.
7. Ball LM, Sulkowski MS, Wolf L, Weiz KB, Tice AD, Dieterich DT. Filgrastim use for interferon induced neutropenia in patients with hepatitis C [Abstract]. Gastroenterology 1999; 116:A1188.
8. Rustgi VK, Lee P, Finnegan S, Ershler W. Safety and efficacy of recombinant human IL-11 (oprelvekin) in combination with interferon/ribavirin therapy in hepatitis C patients with thrombocytopenia [Abstract]. Hepatology 2002; 36:361A.
9. Maddison FE. Embolic therapy of hypersplenism. Invest Radiol 1973; 8:280-281.
10. Vujic I, Lauver JW. Severe complications from partial splenic embolization in patients with liver failure. Br J Radiol 1981; 54:492-495.
11. Alwmark A, Bengmark S, Gullstrand P, Joelsson B, Lunderquist A, Owman T. Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Ann Surg 1982; 196:518-524.
12. Mozes M, Spigos D, Pollak R, Abejo R, Pavel D, Tan W, Jonasson O. Partial splenic embolization, an alternative to splenectomy - results of a prospective, randomized study. Surgery 1984; 96:694-701.
13. N'Kontchou G, Seroe O, Bourcier V, Mohand D, Ajavon Y, Castera L, et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol 2005; 17:179-184.
14. Sakata K, Hirai K, Tanikawa K. A long-term investigation of transcatheter splenic arterial embolization for hypersplenism. Hepato-Gastroenterology 1996;43:309-318.
15. Sangro B, Bilbao I, Herrero I, Corella C, Longo J, Beloqui O, et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 1993; 18:309-314.
16. Pålsson B, Hallen M, Forsberg-Mandahl AM, Alwmark A. Partial splenic embolization - long-term outcome. Langenbecks Arch Surg 2003; 387:421-426.
17. Sockrider CS, Boykin KN, Green J, Marsala A, Mladenka M, McMillan R, Zibari GB. Partial splenic embolization for hypersplenism before and after liver transplantation. Clin Transplant 2002; 16:59-61.
18. Thomas RM, Brems JJ, Guzman-Hartman G, Yong S, Cavaliere P, Van Thiel DH. Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation. Liver Transplant 2003; 9:905-915.
19. Barcena R, Gil-Grande L, Moreno J, Foruny JR, Oton E, Garcia M, et al. Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin. Transplantation 2005; 79:1634-1635.